These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Advances in the treatment of malignant melanoma. Krementz ET, Creach O. Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120 [No Abstract] [Full Text] [Related]
13. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations]. Négrier S, Saiag P, Guillot B, Verola O, Avril MF, Bailly C, Cupissol D, Dalac S, Danino A, Dreno B, Grob JJ, Leccia MT, Renaud-Vilmer C, Bosquet L, National Federation of Cancer Campaign Centers, French Dermatology Society. Ann Dermatol Venereol; 2005 Dec 06; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904 [No Abstract] [Full Text] [Related]
14. Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look. Bluming AZ, Vogel CL, Ziegler JL, Kiryabwire JW. J Natl Cancer Inst; 1972 Jan 06; 48(1):17-24. PubMed ID: 4652371 [No Abstract] [Full Text] [Related]